BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,445 | -1.3% | 2,515,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,476 | -26.0% | 2,515,000 | -22.7% | 0.00% | -25.0% |
Q1 2023 | $3,344 | +3277.8% | 3,252,000 | +3359.6% | 0.00% | – |
Q4 2022 | $99 | -100.0% | 94,000 | -99.7% | 0.00% | -100.0% |
Q1 2021 | $36,314,000 | +9.6% | 35,799,000 | +16.2% | 0.04% | +4.8% |
Q4 2020 | $33,127,000 | -32.7% | 30,799,000 | -34.2% | 0.04% | -39.1% |
Q3 2020 | $49,225,000 | +30.5% | 46,799,000 | +51.9% | 0.07% | +19.0% |
Q2 2020 | $37,715,000 | +17.8% | 30,799,000 | +1.0% | 0.06% | -1.7% |
Q1 2020 | $32,022,000 | -13.2% | 30,485,000 | -12.5% | 0.06% | +11.3% |
Q4 2019 | $36,879,000 | +7.5% | 34,825,000 | 0.0% | 0.05% | -5.4% |
Q3 2019 | $34,319,000 | -5.3% | 34,825,000 | 0.0% | 0.06% | -5.1% |
Q2 2019 | $36,239,000 | +6.4% | 34,825,000 | +4.9% | 0.06% | +5.4% |
Q1 2019 | $34,050,000 | +2.9% | 33,200,000 | 0.0% | 0.06% | -8.2% |
Q4 2018 | $33,097,000 | +75.0% | 33,200,000 | +87.6% | 0.06% | +96.8% |
Q3 2018 | $18,908,000 | +278.7% | 17,700,000 | +254.0% | 0.03% | +244.4% |
Q4 2017 | $4,993,000 | -63.6% | 5,000,000 | -63.0% | 0.01% | -64.0% |
Q3 2017 | $13,710,000 | – | 13,500,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |